argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy in Phase III clinical trials; bullous pemphigoid and idiopathic inflammatory myopathy in Phase II/III clinical trials; and ENHANZE SC in Pre-clinical study. The company is also developing immunology innovation programs, including cusatuzumab for hematological cancer, as well as high risk MDS; ARGX-119, an antibody that targets muscle-specific tyrosine kinase stage; ARGX-117 for severe autoimmune indications; ARGX-118 for airway inflammation; and ARGX-120 to treat autoimmune diseases. In addition, its partnered product candidates include ARGX-115 for the treatment of cancer; ARGX-112 to treat interleukin-22 receptor; and ARGX-114, an antibody directed against the MET receptor. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of ARGENX SE.
ARGENX SE business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of ARGENX SE are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of ARGENX SE , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of ARGENX SE including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of ARGENX SE and all latest updates of the company are provided.
The 2025 version of ARGENX SE report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 ARGENX SE- Key Facts
2.2 ARGENX SE- Geographic Locations
2.3 ARGENX SE- Subsidiaries and Affiliates
2.4 ARGENX SE- Business Divisions
2.5 ARGENX SE- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. ARGENX SE Strategic Analysis Review
3.1 ARGENX SE- Key Strategies
3.2 ARGENX SE- Company Outlook Statement
3.3 ARGENX SE- SWOT Analysis
3.3.1 ARGENX SE- Key Strengths
3.3.2 ARGENX SE- Key Weaknesses
3.3.3 ARGENX SE- Potential Opportunities
3.3.4 ARGENX SE- Potential Threats
3.4 ARGENX SE- Key Competitors
4. Business Description of the Company
4.1 ARGENX SE- Business Overview
4.2 ARGENX SE- Operations by Segment
5 Products and Services Details
5.1 ARGENX SE- Key Products
5.2 ARGENX SE- Key Service Areas
5.3 ARGENX SE- Key Brands
6 Company Developments
6.1 ARGENX SE- Company History
6.2 ARGENX SE- Latest Developments
7 Financial Analysis
7.1 ARGENX SE- Income Statements
7.2 ARGENX SE- Balance Sheet
7.3 ARGENX SE- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 ARGENX SE- Direct Competitors
8.2 ARGENX SE- Competitor Financial Ratios comparison
8.3 ARGENX SE- Competitor Stock Charts Comparison
8.4 ARGENX SE- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!